European Medicines Agency: Approvals January 2021 The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended 13 new medications for approval and three therapeutic indication extensions in its January 2021 meeting. Source: EMA Highlights A conditional marketing authorisation for COVID-19 Vaccine AstraZeneca (COVID-19 Vaccine (ChAdOx1-S [recombinant])) Seffalair Spiromax (salmeterol / fluticasone) and its duplicate BroPair Spiromax (salmeterol / fluticasone) received a positive opinion for the
Reaping the benefits of a Euro-Australian collaboration for biotechs: save on costs and time Cromos Pharma CEO Dr Vlad Bogin is joined by Avance Clinical‘s CEO Yvonne Lungershausen to discuss some of the benefits available to biotechs by availing of a joint initiative that combines Australian tax benefits for clinical research with exceptional patient recruitment and retention in Eastern European markets. Read more here>> This presentation was prepared January
Clinical trials: how to enroll on time, stay on budget and not compromise data quality Clinical trials: how to enroll on time, stay on budget and not compromise data quality Stephanie Finnegan, COO of Cromos Pharma delivers key insights into how to maintain study and data integrity when facing cost and time constraints. When time and money is of the essence how can you achieve patient recruitment targets? This presentation
